chronic immune thrombocytopenia
Haematology · 2010–2022
2decisions
2medicines
1carried consumer input
8individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| avatrombopag Treatment of severe thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenia purpura (ITP) who have had an inadequate response or are… | Nov 2022 | Recommended with restriction | 8 individuals |
| eltrombopag olamine For initial treatment, as the sole PBS-subsidised thrombopoietin receptor agonist (TRA), of an adult patient with chronic immune (idiopathic) thrombocytopenia… | Nov 2010 | Recommended | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.